These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 6142461)

  • 1. 1-Benzylimidazole, a thromboxane synthetase inhibitor acutely lowers blood pressure mainly by alpha-adrenoceptor blockade in spontaneously hypertensive rats (SHR).
    Lucas J; Chan PS; Mateja N; Cervoni P; Ronsberg MA; Lipchuck LM
    Prostaglandins Leukot Med; 1983 Dec; 12(4):409-21. PubMed ID: 6142461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of OKY-046, a selective thromboxane synthetase inhibitor, on blood pressure and thromboxane synthesis in spontaneously hypertensive rats.
    Gomi T; Ikeda T; Ishimitsu T; Uehara Y
    Prostaglandins Leukot Essent Fatty Acids; 1989 Sep; 37(3):139-44. PubMed ID: 2608692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stimulation of vessel wall prostacyclin by selective thromboxane synthetase inhibitor OKY 1581.
    Mehta J; Mehta P; Ostrowski N
    Prostaglandins Leukot Med; 1983 Sep; 12(1):49-52. PubMed ID: 6356153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of a thromboxane synthetase inhibitor, OKY-046, on urinary excretion of immunoreactive thromboxane B2 and 6-keto-prostaglandin F1 alpha in patients with ischemic cerebrovascular disease.
    Uyama O; Nagatsuka K; Nakabayashi S; Isaka Y; Yoneda S; Kimura K; Abe H
    Stroke; 1985; 16(2):241-4. PubMed ID: 3883580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of OKY-046, a thromboxane synthetase inhibitor, on renal thromboxane synthesis in spontaneously hypertensive rat].
    Nakayama D; Ikeda T
    Nihon Jinzo Gakkai Shi; 1988 Jan; 30(1):79-84. PubMed ID: 3386014
    [No Abstract]   [Full Text] [Related]  

  • 6. Influence of selective thromboxane synthetase blocker CGS-13080 on thromboxane and prostacyclin biosynthesis in whole blood: evidence for synthesis of prostacyclin by leukocytes from platelet-derived endoperoxides.
    Mehta J; Mehta P; Lawson DL; Ostrowski N; Brigmon L
    J Lab Clin Med; 1985 Sep; 106(3):246-52. PubMed ID: 3928780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thromboxane synthetase inhibitor UK38,485 lowers blood pressure in the adult spontaneously hypertensive rat.
    Uderman HD; Jackson EK; Puett D; Workman RJ
    J Cardiovasc Pharmacol; 1984; 6(5):969-72. PubMed ID: 6209508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delay of the initiation of hypertension in spontaneously hypertensive rats by CV-4151, a specific thromboxane A2 synthetase inhibitor.
    Shibouta Y; Terashita Z; Inada Y; Nishikawa K
    Eur J Pharmacol; 1985 Feb; 109(2):135-44. PubMed ID: 3922775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thromboxane inhibition potentiates antihypertensive effects of alpha 1 adrenoceptor antagonists in the rat.
    Takada S; Numabe A; Hirawa N; Yagi S; Uehara Y
    Prostaglandins Leukot Essent Fatty Acids; 1997 Feb; 56(2):127-34. PubMed ID: 9051722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Roles of vascular and renal thromboxanes in the antihypertensive effects of alpha 1 adrenoceptor antagonists].
    Takada S; Uehara Y; Hirawa N; Numabe A; Yagi S
    Nihon Jinzo Gakkai Shi; 1989 Sep; 31(9):969-75. PubMed ID: 2573747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of thromboxane synthetase inhibitor (OKY-046) on placental blood flow, placental weight and fetal weight in normotensive and spontaneously hypertensive rats.
    Furuhashi N; Tsujiei M; Kimura H; Nagae H; Yajima A
    Gynecol Obstet Invest; 1993; 35(1):23-6. PubMed ID: 8449429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thromboxane synthesis and blood pressure in spontaneously hypertensive rats.
    Purkerson ML; Martin KJ; Yates J; Kissane JM; Klahr S
    Hypertension; 1986 Dec; 8(12):1113-20. PubMed ID: 3793195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of endotoxin-induced pulmonary hypertension in primates by the use of a selective thromboxane synthetase inhibitor, OKY 1581.
    Casey LC; Fletcher JR; Zmudka MI; Ramwell PW
    J Pharmacol Exp Ther; 1982 Aug; 222(2):441-6. PubMed ID: 6896528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of thromboxane synthetase inhibitor on cerebral circulation and metabolism during experimental cerebral ischemia in spontaneously hypertensive rats.
    Sadoshima S; Ooboshi H; Okada Y; Yao H; Ishitsuka T; Fujishima M
    Eur J Pharmacol; 1989 Oct; 169(1):75-83. PubMed ID: 2513212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potentiation by dazoxiben, a thromboxane synthetase inhibitor, of platelet aggregation inhibitory activity of a thromboxane receptor antagonist and of prostacyclin.
    Bertele V; De Gaetano G
    Eur J Pharmacol; 1982 Dec; 85(3-4):331-3. PubMed ID: 6295787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of thromboxane and 12-HPETE formation by dazoxiben and its two thiophenic acid-substituted derivatives.
    Smith EF; Darius H; Ferber H; Schrör K
    Eur J Pharmacol; 1985 Jun; 112(2):161-9. PubMed ID: 3896821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological studies on the TXA2 synthetase inhibitor (E)-3-[p-(1H-imidazol-1-ylmethyl)phenyl]-2-propenoic acid (OKY-046).
    Hiraku S; Taniguchi K; Wakitani K; Omawari N; Kira H; Miyamoto T; Okegawa T; Kawasaki A; Ujiie A
    Jpn J Pharmacol; 1986 Jul; 41(3):393-401. PubMed ID: 3093741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of a thromboxane A2-receptor antagonist, a thromboxane synthetase inhibitor and aspirin on prostaglandin I2 production in endothelium-intact and -injured aorta of guinea pigs.
    Higo K; Karasawa A
    Jpn J Pharmacol; 1994 Dec; 66(4):471-9. PubMed ID: 7723224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of the prostaglandin-thromboxane system in the development and maintenance of spontaneous hypertension in the rat.
    Yasujima M; Abe K; Tanno M; Kohzuki M; Sato M; Omata K; Takeuchi K; Hagino T; Yoshinaga K
    Agents Actions Suppl; 1987; 22():133-8. PubMed ID: 3124554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thromboxane A2 and the development of hypertension in spontaneously hypertensive rats.
    Stier CT; Itskovitz HD
    Eur J Pharmacol; 1988 Jan; 146(1):129-35. PubMed ID: 3350054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.